Keywords: hsc73/cell surface expression/Triton X-l 14 phase separation/epitope mapping ABSTRACT. It has been argued that 70 kDa heat shock cognate (hsc73)-like molecules may be expressed on the surface of certain cells, but direct evidence of this has yet to be found. To clarify whether this molecule belongs to hsc73 itself, the membrane protein fraction of Daudi cells was isolated by Triton X-114 phase separation and the reactivity of this membraneprotein fraction was assessed with monoclonal antibodies (mAbs) which react with 70 kDa heat shock protein (hsp) family, i.e., NT22, A15 and 3A3. In western blotting analysis, mAbNT22-defined protein (pNT22) was clearly detected as a membraneprotein of Daudi cells with an approximate molecular size of 70 kDa, whereas pNT22was not recognized by anti-cytoplasmic hsc73/hsp72 mAbs A15 or 3A3. By using deleted recombinant hsc73 proteins, it was determined that mAb NT22 recognizes the N-terminal 350-372 amino acid stretches of the hsc73 protein. mAbNT22 also reacted with the cell surface protein of Daudi cells in FACSanalysis. Taken together, our present data strongly suggest that pNT22 may be a novel hsc73-like protein that is localized in the plasma membrane.
It is knownthat the heat shock proteins (hsp) act as molecular chaperones in various intracellular compartments (4, 10, ll, 13, 19) . Although these proteins do not have the known transmembrane portion in their primary amino acid structures, several studies have suggested that certain molecular chaperones, such as hsp60 (17), hsp70 (20, 24, 25, 26) and hsp90 (22) , are expressed on the cell surface. Wereported previously that a mAb#067-defined 70kDa protein can be expressed on the cell surface of rat fibroblast transformed by ras-oncogene. This protein was recognized by anti-rat hsc73mAb, and its expression was enhanced by treatment of cells with heat and other physical and chemical stresses, implying that mAb #067-defined antigen may belong to the 70 kDa hsp family (25) . Furthermore, it was suggested that they may play the role of an antigen-presenting molecule to CD4~, CD8-, double negative (DN) T cells (24, 25) . This notion is intriguing since it indicates a very novel presentation mechanism. However, it is not known so far how and which sub family of 70 kDa hsp could be expressed on the cell surface. Since no knownmammalian70 kDa hsp with the hydrophobic transmembrane portion has been ever reported, there is a possibility that a new member of the 70 kDa hsp family with such a portion is localized in the plasma membrane.
Meanwhile, we have previously reported that antihsc73 specific mAbNT22 could also detect the cell surface molecule expressed on EBV-transformed B cell lines, such as Daudi and Raji cells, and that the expression of this molecule was also enhanced by several stressors, such as heat, arsenic acid and L-azetidine-2-carboxilic acid (26) . In the current investigation, we used mAbNT22 and the newly-developed anti-cytoplasmic hsc73/hsp72 mAbA15, and assessed the interaction between these mAbsand membraneproteins prepared with Triton X-114 (TTX-114). The data implied that mAb NT22-defined (pNT22) antigen, but not mAbA15-defined antigen, is localized in the plasma membrane, strongly suggesting that a novel hsc73-like protein is being expressed on the cell surface.
MATERIALS AND METHOD
Cells and Antibodies Daudi Burkitt's lymphomacells were cultured in Dulbecco's modified MEMsupplemented with 10% fetal calf serum and 2 mMof L-glutamine. Anti-hsc73 mAbNT22 with IgM isotype was described earlier (26) . Mouse mAbsagainst cytoplasmic hsc73/hsp72 were obtained following methods described elsewhere (27) . Briefly, hsc73/hsp72-containing ATP-binding proteins were used to immunize mice. Splenic lymphocytes of these mice were fused with NS-1 myelomacells and mAbs Fig. 1 . Procedure of phase separation of membraneproteins using Triton X-114. The cell lysate prepared with Triton X-114 is incubated at 37°C (a). This incubation makes the lysate cloudy (b). After centrifugation, the lysate is separated into the aqueous and the detergent phases which contain the cytoplasmic proteins and the amphiphilic membraneproteins, respectively (c). After two more similar rounds (b-e) of phase separation of membrane proteins, the consequent aqueous (f) and detergent phase preparations (g) were used for the analysis.
were obtained. After limiting dilution, mAb A15 with IgM isotype was selected. In the present study, we also used antihsc73/hsp72 mAbs, i.e., 3A3, 5A5 and 2A4 (Affinity Bioreagents, Neshanic Station, NJ USA). It was shown that 5A5, 2A4, and A15 mAbs react with cytoplasmic hsc73/hsp72. Anti-hsp40 polyclonal antibody was obtained from a rabbit immunized with recombinant human hsp40. Anti-CD20 mAb TB2-2B3 was described elsewhere (16). 
Construction

FACS analysis
FACSanalysis for detection of the cell surface antigens was described earlier (26) . The normal mouse IgM (DAKO; A/S, Denmark) was used as a negative control in FACSanalysis.
Phase separation of membraneproteins with Triton X-114 and western blotting analysis
The membrane fraction was prepared by the method described in Bordier (3) with some modifications as illustrated in Fig. 1 . 1 x 107 Daudi cells were washed twice with PBS. The cells were lysed in 1 ml of \% TTX-114, 10 mMTris-HCl, 250 mMNaCl, pH 8.0. The cell lysate was separated from the cell debris by centrifugation at 14,500 rpm for 30 min at 4°C ((a) in Fig. 1 ). The supernatant was incubated at 37°C for 5 min and centrifuged at 10,000 rpm at room temperature for 5 min. By this incubation and centrifugation, the cell lysate became cloudy (b) and the detergent phase was found as an oily layer at the bottom of the tube (c). or reactivity with possible proteolytic fragments of recombinant proteins was observed (Fig. 3c) . As summarized in Table. I, these results indicated that the epitopes of mAbNT22and mAbA15 were located in Nterminal 350-372 and 541-630 amino acids of hsc73, respectively. It was also shown that mAb3A3-defined epitope was located in N-terminal 373-540. This is reasonable since it was identified that the epitope of mAb3A3 is localized in N-terminal 504-617 as previous reported (9).
Reaction of anti-hsc73/hsp72 mAbswith the cell surface antigens To confirm whether these mAbscould detect the antigens expressed on the cell surface, we used live Daudi cells in FACS analysis. As shown in Fig. 4 , mAb NT22, but not anti-cytoplasmic hsc73/hsp72 mAb A15 or mAb3A3, could react with the cell surface molecule expressed on Daudi cells. These observations suggested that an NT22-defined pNT22 protein was expressed on the cell surface.
mAbreactivity of membrane proteins using phase separation with Triton X-114 To further assess whether pNT22 could be localized in the membrane fraction, we used the phase separation method in preparation of membrane proteins of Daudi cells with TTX-1 14. Namely, hydrophilic proteins were excluded in the aqueous phase, and amphiphilic integral membraneproteins were recovered in the detergent phase. Weused the aqueous phase as the cytoplas-
Fluorescence intensity mic protein fraction and the detergent phase as the whole membrane protein fraction for further analysis. After phase separation, aliquots of both fractions were analyzed by SDS-PAGE and western blotting.
Wefirst assessed the separation efficiency of cytoplasmic and membrane proteins with TTX-114. As shown in Fig. 5 , a polyclonal anti-hsp40 antibody detected multiple bands of hsp40, presumably complexed with various kinds of substrate, exclusively in the cytoplasmic protein fraction, while one of CD20, a typical membraneprotein, was stained only in the membrane protein fraction, indicating that this phase separation for cytoplasmic and membraneproteins was very strictly done. By using the same samples, it was clearly shown that mAbNT22 and mAb3A3 reacted to molecules of approximately 70 kDa in molecular size in the membraneprotein fraction, as well as cytoplasmic hsc73/hsp72. NT22also reacted with multiple proteins of various molecular sizes in the cytoplasmic fraction. Furthermore, NT22 and 3A3 could also detect a band with approximately 30kDa in molecular size from membranefraction, but, this seemed to be a nonspecific reaction or degradation protein product, since it was not detected in Fig. 6 . In contrast, mAb A15 only stained cytoplasmic hsc73/hsp72. Moreover, to exclude the possibility that the molecule detected by mAbNT22in the detergent phase was contaminated from cytoplasmic hsc73/hsp72, we assessed whether pNT22could be detected by conventional anti-cytoplasmic hsc73/hsp72 antibodies. As shown in Fig. 6 , the band corresponding to pNT22 was not detected by anticytoplasmic hsc73/hsp72 mAbs such as 5A5, 2A4, and A15. These data indicated that pNT22 was not cytoplasmic hsc73 itself. Furthermore, it is noteworthy that pNT22 had a smaller molecular weight than mAb3A3-defined molecule (p3A3), suggesting that pNT22 was distinct from p3A3. The FACS profile indicates that pNT22might be a hsc73-like novel membraneprotein.
DISCUSSION
Recent reports have suggested that certain cells express hsp, such as hsp60, hsp70, and hsp90 on the cell surface (17, 20, 22, 24, 25, 26) . We reported previously that an hsp70-like molecule could express itself on the cell surface, suggesting that such molecules may act as the antigen-presenting molecules to CD3+, CD4~, CD8-, NKR-P1-DNT cells (24, 25) . However, no known mammalian hsp70 with the hydrophobic transmembraneregion has been reported so far. Therefore, it is possible that a newmemberof hsp70 with a transmembraneregion is localized in the plasma membrane.
In the current investigation, we suggested that the mAbNT22-defined antigen, pNT22, might be localized in the plasma membrane. In conjunction with our previous data, it is highly likely that pNT22 is an hsc73-related novel membraneprotein.
To resolve the problem of whether the cell surfaceexpressed pNT22belongs to conventional cytoplasmic hsc73 itself, we adopted the phase separation technique using Triton X-114 to prepare the membrane fraction of Daudi cells (3) . By this separation, integral membraneproteins were efficiently recovered in the detergent phase. Indeed, cytoplasmic HSP40appeared to be exclusively stained in the aqueous phase, whereas CD20, a typical membraneprotein, was only stained in the detergent phase. This indicated that the phase sepa-ration was very strictly performed, and that the detergent phase contained almost pure membrane proteins. Using this membraneprotein fraction, we carried out western blotting analysis with anti-hsc73/hsp72 mAbs. The results showed that mAbNT22reacted to approximately 70 kDa protein pNT22in the membrane protein fraction as well as in the cytoplasmic protein fraction. There was still a possibility that pNT22 in the membraneprotein fraction was contaminated by cytoplasmic hsc73, because hsc73 is amply expressed in the cytoplasm. To eliminate this possibility, we employed mAbsthat react with conventional cytoplasmic hsc73/hsp72. Namely, if pNT22 was a contaminated cytoplasmic hsc73, anti cytoplasmic hsc73/hsp72 mAbsshould detect the molecule even in the detergent phase. However, pNT22was not detected by these antibodies, indicating that pNT22 in the membrane fraction was not a contamination of cytoplasmic hsc73, but was localized in the membranefraction. It was also interesting that the molecular size of pNT22was different from that of p3A3 in the membrane fraction. This may imply that pNT22 is a novel hsc73-like membrane protein.
It should be noted that the detergent phase contained proteins of all cellular membranes such as plasmamembrane, mitochondrial membranesor endoplasmic reticulum and Golgi apparatus. However, FACS analysis showed that pNT22was stained on the cell surface. This means that pNT22is at least localized on the plasma membrane. On the other hand, FACSanalysis indicated that p3A3 was not detected on the cell surface. These results imply two possibilities: 1) that p3A3 is localized in the intracellular membraneportion such as mitochondrial membranes or endoplasmic reticulum; and 2) that p3A3 is localized on the plasma membrane, but that the mAb3A3-defined epitope is not exposed to the cell surface. Consequently, we could not identify p3A3as a cell-surface localized membraneprotein.
Meanwhile, the results of epitope mapping using deleted hsc73 proteins showed that the epitope defined by NT22 was located in N-terminal 350-372 of hsc73. This region of hsc73 is highly conserved among the hsp70 family proteins of different species (2) such as metazoan (12), yeast (5), Drosophila (15), plants (18) and mammals (1, 6, 8, 14, 21) . Indeed, a homology search with this epitope sequence from the available computer database showed that no other molecules than the hsp70 family, including hsc73, hsp72, BiP and mitochondrial hsp75, were picked up. One could not exclude the possibility that pNT22 is a non hsc73-related membraneprotein which contains the above sequence.
However, as reported previously (26), pNT22 expression is enhanced by several stress treatments. Therefore, it is highly likely that the protein containing this sequence belongs to the hsp70 family. Thus, it may be hypothesized that pNT22is a new memberof the hsp70 family with a plasma membranelocalized form. Finally, the biological function and genetic structure of pNT22 has not been identified so far. However, the fact that pNT22was exclusively recovered in the detergent phase suggested that pNT22 was localized on the plasma membrane either as an integral membrane protein, or as a glycosyl phosphatidyl inositol (GPI)-anchored protein (7) or as a protein associated with a distinct transmembrane protein. Our preliminary studies excluded the possibility that pNT22 was a GPIanchored protein, because phospholipase C treatment of cells did not influence the cell surface expression of pNT22. Meanwhile, there is the possibility that pNT22 mayassociate with a distinct transmembrane protein as a resident molecular chaperone in the plasma membrane or as a transporter of some antigenic peptides from intracellular to extracellular spaces (23) . Indeed, our previous studies suggested that mAb#067 definedrat hsc73-like protein acted as an antigen presenting molecule on the cell membrane and interacted with CD3+, CD4~, CD8-DNT cytotoxic cells (24, 25) . One could expect pNT22 to act similar to an mAb #067-defined protein. However, since NT22 could not make immunoprecipitates, it is not clear whether pNT22 is the same as 067-defined molecules. Weare now undertaking an identification of a gene encoding pNT22. Through this molecular cloning, the biological function and the cell surface expression mechanism should be totally explained.
